关键词：尿失禁；吊索尿道；放置灵活；手术网系统；膀胱颈支持；减少失禁；TOT；TVT
摘 要：Urinary incontinence slings are flexible surgical mesh systems placed under the urethra or the bladder neck for support and to minimize incontinence efficiently. The procedure uses strips of tissues or a synthetic mesh to create a hammock-like fixture that wraps around the bladder neck. Urinary incontinence slings are also called urethral support slings. Urinary slings are of two major types: TOT and TVT.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Indications for Use of Urinary Slings

06.1 Urinary Incontinence

06.2 Types of Urinary Incontinence

06.2.1 Stress Incontinence

06.2.2 Urge Incontinence

06.2.3 Mixed Incontinence

06.2.4 Functional Incontinence

06.2.5 Overflow Incontinence

06.3 Pelvic Organ Prolapse

06.4 Overactive Bladder

06.5 Treatment Techniques for Urinary Incontinence

07. SUI

07.1 Patient Profile

07.2 Treatment Comparison

08. Market Landscape

08.1 Market Overview

08.2 Market Size and Forecast

08.3 Five Forces Analysis

09. Market Segmentation by Type

09.1 Vaginal Slings

09.2 Male Slings

09.3 Vaginal Slings Market in US

09.3.1 Market Size and Forecast

09.4 Male Slings Market in US

09.4.1 Market Size and Forecast

10. Vaginal Slings Market in US

10.1 Mid-Urethral Slings

10.2 Single-incision Slings

10.3 TOT Slings Market in US

10.3.1 Market Size and Forecast

10.4 TVT Slings Market in US

10.4.1 Market Size and Forecast

10.5 Single-incision Slings Market in US

10.5.1 Market Size and Forecast

11. Male Slings Market in the US

11.1.1 Market Size and Forecast

12. Reimbursement Scenario

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

20.1 Competitive Scenario

20.2 Market Share Analysis 2014

20.3 Other Prominent Vendors

21. Key Vendor Analysis

21.1 American Medical Systems

21.1.1 Key Facts

21.1.2 Business Overview

21.1.3 Key Brands

21.1.4 Therapeutic Areas

21.1.5 Geographical Segmentation

21.1.6 Business Strategy

21.1.7 Recent Developments

21.1.8 SWOT Analysis

21.2 Boston Scientific

21.2.1 Key Facts

21.2.2 Business Overview

21.2.3 Key Products

21.2.4 Key Products in Cardiovascular Segment

21.2.5 Key Products in MedSurg Segment

21.2.6 Key Products in Rhythm Management Segment

21.2.7 Business Segmentation by Revenue 2013

21.2.8 Business Segmentation by Revenue 2012 and 2013

21.2.9 Geographical Segmentation by Revenue 2013

21.2.10 Business Strategy

21.2.11 Recent Developments

21.2.12 SWOT Analysis

21.3 Coloplast

21.3.1 Key Facts

21.3.2 Business Overview

21.3.3 Business Segmentation by Revenue 2014

21.3.4 Business Segmentation by Revenue 2013 and 2014

21.3.5 Geographical Segmentation by Revenue 2014

21.3.6 Business Strategy

21.3.7 Key Developments

21.3.8 SWOT Analysis

21.4 C. R. Bard

21.4.1 Key Facts

21.4.2 Business Overview

21.4.3 Product Segmentation by Revenue 2013

21.4.4 Product Segmentation by Revenue 2012 and 2013

21.4.5 Geographical Segmentation by Revenue 2013

21.4.6 Business Strategy

21.4.7 Recent Developments

21.4.8 SWOT Analysis

21.5 Johnson & Johnson

21.5.1 Key Facts

21.5.2 Business Overview

21.5.3 Business Segmentation by Revenue 2013

21.5.4 Business Segmentation by Revenue 2012 and 2013

21.5.5 Geographical Segmentation by Revenue 2013

21.5.6 Business Strategy

21.5.7 Recent Developments

21.5.8 SWOT Analysis

22. Other Reports in this Series